Which pharmaceutical product launch was the first FDA-approved monoclonal antibody for treating breast cancer, representing a pioneering targeted therapy approach in oncology?

The pharmaceutical industry regularly introduces innovative products that transform patient care. This trivia focuses on major product launches that changed treatment paradigms in medicine. Test your knowledge about these groundbreaking medications that established new therapeutic categories or dramatically improved treatment options for patients worldwide.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Herceptin (trastuzumab) by Genentech/Roche in 1998
• Avastin (bevacizumab) by Genentech/Roche in 2004
• Gleevec (imatinib) by Novartis in 2001
• Rituxan (rituximab) by Biogen/Genentech in 1997

Powered by AIPolls.Net — AI-powered real-time polling platform.